1. Introduction
The order Chlamydiales consists of obligate intracellular Gram-negative bacteria that infect an extensive range of domestic and wildlife hosts including birds, mammals, marsupials, amphibians, and reptiles [1,2,3]. To date, this order consists of nine families: Chlamydiaceae, Clavichlamydiaceae, Cribchlamydiaceae, Parachlamydiaceae, Parilichlamydiaceae, Piscichlamydiaceae, Rhabdochlamydiaceae, Simkaniaceae, and Waddliaceae. The Chlamydiaceae family currently consists of eleven Chlamydia species with variable pathogenicity and different preferential host [4]: C. abortus, C. avium, C. caviae, C. felis, C. gallinacea, C. muridarum, C. pecorum, C. pneumoniae, C. psittaci, C. suis, and C. trachomatis, as well as three species at Candidatus (Ca.) status: Ca. C. ibidis, Ca. C. sanzinia, and Ca. C. corallus. The newly described Chlamydiifrater genus comprises the species named Chlamydiifrater phoenicopteri sp. nov. and Chlamydiifrater volucris sp. nov. [4]. Among them, C. trachomatis and C. pneumoniae species are primarily human pathogens, while the other species are bacteria of veterinary interest that infect a variety of wild and domestic animals and that can be occasionally transmitted to human [5]. Chlamydia psittaci infection has been reported in several species of birds (which represent the main reservoir of the zoonotic pathogen) and in non-avian hosts [6]. In humans, the bacterium causes mainly respiratory infections with fever, chills, headache, myalgia, nonproductive cough, and respiratory distress as the most frequently reported clinical symptom [7]. Gastrointestinal symptoms and skin rashes have been also observed [7]. Rare complications could include myocarditis, encephalitis, hepatitis, keratoconjunctivitis, acute respiratory distress syndrome, and multiple-organ failure, with development of ocular lymphoma [8]. Serious or life-threatening illness can occur when the signs of psittacosis are not recognized [9,10]. The main route of human infection is by the inhalation of aerosolized organisms from dried avian feces or respiratory tract secretions of infected birds [11]. Other means of exposure include mouth-to-beak contact and handling of infected birds’ plumage and tissues. Rarely, human-to-human transmission has been reported with the epidemiology of human infections that always reflects the circulation of the bacterium in animal reservoirs [12]. Several studies have recently detected and performed molecular characterizations of C. psittaci in fetoplacental material in horses [13,14]. Also, the prevalence of C. psittaci has been evaluated in healthy mares/foals [15]. Horses are considered occasional hosts of C. psittaci, and the infection has been associated with pneumonia, conjunctivitis, and abortion [16]. In the literature, it is clearly stated that C. psittaci is a known cause of equine abortion and reproductive loss, and the association between C. psittaci and equine abortion has been evaluated with zoonotic implications for humans [2,17].
Moreover, although C. psittaci is an obligate intracellular bacterium, it has been documented in environmental samples and waters as reticulate bodies that may represent a long-term environmental reservoir of the bacterium [9]. Although previous studies in infected mares reported reproductive (such as genital infection, occasional abortion, and infertility) and respiratory signs (pneumonia, conjunctivitis, and polyarthritis) attributed to C. psittaci [18,19] and rarely to C. abortus, the relationships between equine abortion and chlamydial infection are still being studied [20]. This pilot epidemiological study investigated the presence of Chlamydia species in apparently healthy horses by also providing preliminary information about their potential role as reservoirs and sources of zoonotic infection. The results arising from this study would represent the evidence-based information necessary to carry out a large-scale study aimed at estimating the true prevalence of chlamydial infections in Sardinian breeding horses.
2. Materials and Methods
2.1. Study Area
Sardinia is an island of Italy with a total area of 24,100 km2, characterized by various eco-systems because of the presence of mountains, forests, plains, largely uninhabited areas, waterways, long sandy beaches, and rocky shores. Furthermore, the island is characterized by many autochthonous animal species. Among them, there are three horse breeds native to the island, named Giara, Sarcidano, and Sardinian Anglo-Arab, that are classified as “at risk” by the FAO (
Considering the need to gather prior information about the prevalence of chlamydial infections in Sardinian breeding horses, a pilot study was planned and developed to evaluate possible critical steps in the process of intervention and sample testing. A small-scale test of the methods and procedures was carried out to evaluate the feasibility of a prevalence study, without claims of inference. On the basis of the results obtained, larger-scale tests could be performed in future studies. Thus, sample size calculation was not performed, and participation in this investigation was solely on a voluntary basis.
During the period February 2021 to May 2022, horse and environmental samples were collected from 17 horse centers located in the central-northern part of Sardinia as shown in Figure 1. These locations were chosen based on the willingness of the owners to participate in the sampling, which was therefore carried out for convenience. Clinical swab samples were collected by veterinarians according to good practice and with the agreement of owners.
2.2. Origin of the Samples
A total of sixty horses (39 mares and 21 stallions) used for breeding were voluntarily included in this study. Baseline characteristics of these animals are reported in Table 1. The 39 mares were aged between 5 and 25 years old (mean = 14.3, SD = 5.1), including 17 Anglo-Arabians, 14 Standardbreds, 3 Arabians, 3 Thoroughbreds, and 2 Italian Saddles. The 21 stallions (12 Anglo-Arabians, 4 Arabians, 3 Thoroughbreds, 1 Oldenburg, and 1 Luxembourg Warmblood) were aged between 6 and 29 years old (mean = 15.9, SD = 5.6).
Ethical review and approval were waived for this study, as this study did not involve any animal experiments. Samples were collected from horses using standard procedures as suggested by AGRIS, Servizio Ricerca Qualità e Valorizzazione delle Produzioni Equine, Ozieri, Italy, and submitted to the Experimental Zooprofilactic Institute of Sardinia for Chlamydia screening. Special authorization for sampling activities was not necessary; this action is regulated by the Italian Ministry of Health and performed in the case of infectious diseases.
2.3. Sampling Protocol
A qualified veterinarian conducted an accurate physical examination of each horse assessing overall body condition, skeletal development, state of nutrition and muscular tone, sensory state, mucous membranes, hydration status, lymph nodes, temperature, pulse, breath, and organic functions [21]. All horses from this study were also evaluated by ultrasonography of the reproductive tract, using a 5 MHz linear probe.
2.3.1. Blood Collection
Blood samples were taken from the jugular vein using EDTA-containing vials and stored at 4 °C during their transportation to the laboratory. A basic hematological test was performed by analyzing the red blood cell (RBC) count, hemoglobin (HGB), hematocrit (HCT), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), MCH concentration (MCHC), red blood cell distribution width (RDW), platelet, and white blood cell (WBC) count. The concentrations of alkaline phosphatase, aspartate aminotransferase, gamma-glutamyl transpeptidase, creatine kinase, total protein concentration, albumin, total bilirubin, and triglycerides [22] were also evaluated by blood biochemical analysis.
2.3.2. Collection of Swabs
During the estrous follicular phase, uterine (n = 27) and vaginal swabs (n = 39) were collected from each mare. Prior to the swab collection, an accurate disinfection of the vulva and perineal area was performed with povidone iodine (Betadine®, MEDA Pharma S.p.A., Milan, Italy) [23]. The urethral swabs from 21 stallions were also collected after cleaning of the penis with warm clean water to remove smegma, dead skin cells, and other debris. The penis was then dried using disposable paper [23].
The urethral swab was then inserted into the urethra to a depth of 2–4 cm and turned several times. Seminal fluid was also collected from the stallions using a “home-made” artificial vagina (INRA modified) with the stallion mounting a Franches-Montagnes mare or a phantom depending on the stallion [24]. The collected samples were stored at −20 °C until analyses.
Eight collection areas were selected as follows: the senior mares’ area, the mares’ pond, the foals’ area, the service center, the general pond, Garden 1, Garden 2, and the stallions’ area. For each area of collection, one environmental swab and two samples of water (either directly from the pond or from the drinkers) were obtained. Dry swabs were streaked in the selected area, collected at 4 °C in sterile wrapping; around 1.5 mL was held in a microtube (Eppendorf, Hilden, Germany) at 4 °C and then transferred to the IZS laboratory for further examination.
2.3.3. Ectoparasite Collection
As part of the control ticks and tick-borne diseases program, ectoparasites were also collected from the sampled horses following the removal guidelines of the Centers for Disease Control (CDC;
2.4. Direct Immunofluorescence Test
To determine the presence of Chlamydia, vaginal, uterine, urethral, and environmental swabs were analyzed by direct immunofluorescence (IFD) using a commercial kit (IFD; IMAGEN Chlamydia test; Oxoid Ltd., Basinstoke, UK). Before analysis, the swabs were rolled, by pressure, on the microscope slide. The slides were examined and interpreted using an epifluorescence microscope. The results were categorized as positive if extracellular elementary bodies (EBs) were visible as very small bright apple-green-fluorescent smooth-edged disc shapes approximately 300 nm in diameter. The background observed is usually made of red counterstained cells and cellular debris. A positive control slide, provided by the kit IMAGEN, was included in each IFD test.
2.5. DNA Extraction
DNA from swabs, seminal fluid, water samples, ticks, and flies was extracted using the commercial DNeasy Blood and Tissue Kit (QIAGEN, Hilden, Germany) following the manufacturer’s instructions with some modifications such as lysis in 600 μL ATL buffer and 60 μL Proteinase K for ectoparasites. The DNA extracted was stored at 4 °C until use.
2.6. Screening of Chlamydia spp. by PCR Amplification
All DNA samples were tested by three different PCR protocols. DNA of Chlamydia abortus (isolated from abortion product in Sardinia [26]) and Chlamydia psittaci (DNA provided by Centro di Referenza Nazionale Clamidiosi, IZS della Lombardia e dell’Emilia Romagna, Sezione Diagnostica di Pavia, Italy) and autoclaved water were used as positive and negative control, respectively, and included in each amplification protocol. The first assay allowed us to identify members of the Chlamydiales order by amplifying a 256-bp fragment of the 16S rRNA gene. The protocol was carried out using the primers 16SFor2 (5′ CGTGGATGAGGCATGCAAGTCGA 3′) and 16SRev6 (5′ ATCTCTCAATCCGCCTAGACGTCA 3′) as previously described [27]. The amplification was performed in an automated DNA thermal cycle (GeneAmp PCR Systems 2400 and 9700; Applied Biosystems, Courtaboeuf, France) with a temperature profile as follows: an initial denaturation at 95 °C for 15 min, followed by 40 cycles of denaturation at 94 °C for 60 s, annealing at 60 °C for 30 s, and extension at 72 °C for 60 s, with a final extension step at 72 °C for 5 min. PCR products were verified by electrophoresis in 1.5% agarose gel stained with SYBR™ Safe DNA Gel Stain (Thermo Fisher Scientific Inc., Waltham, MA, USA) and then watched under UV transillumination in an Image Master VDS-CL System (Amersham Biosciences Europe GmbH, Milano, Italy).
The 16S rRNA positive DNA samples were successively submitted to the second PCR protocol described by Chisu et al. [27], which allows us to identify C. abortus using oligonucleotide primers pmp1 (5′-ATGAAACATCCAGTCTACTGG-3’) and pmp2 (5′-TTGTGTAGTAATATTATCAAA-3′), which amplify a 318 bp fragment of the pmp gene. Each reaction consisted of 12.5 µL of QuantiTect Probe PCR Master Mix (Qiagen, Toronto, ON, Canada; 1X final concentration), Milli-Q water RNAse-free (9.5 µL), 1 µL of each forward and reverse primer (25 pmol/µL), and 1 µL of DNA template, in a final volume of 25 µL.
The 16S rRNA positive samples were also submitted to the third PCR protocol that employed the oligonucleotide primers Cpsitt F (5′-GCTACGGGTTCCGCTCT-3′) and Cpsitt R (5′-TTTGTTGATYTGAATCGAAGC-3′), which amplified a 1041 bp fragment of the ompA gene specific to C. psittaci species [28].
2.7. Purification and Sequencing
The 16S rRNA and ompA amplified products were purified using the QIAquick Purification Kit (QIAGEN, Hilden, Germany) according to the manufacturer’s protocol. The purified amplicons were bidirectionally sequenced using an ABI Prism BigDye Terminator Cycle Sequencing Ready Reaction Kit (Applied Biosystems, Foster City, CA, USA). The obtained forward and reverse reads were corrected using ChromasPro software version 2.2 (Technelysium, Helensvale, Australia). Consensus sequences were aligned with CLUSTALX [29] and then compared with similar sequences available in the GenBank database using the BLASTn (Nucleotide BLAST) search tool (
The generated ompA sequences were then deposited in Gen Bank under the accession number PP429546-PP429550.
2.8. Statistical Analysis
Considering the non-inferential purpose of this work, descriptive statistics of the samples collected and the associated laboratory results are presented. The analysis was stratified between sex (mares or stallions) and young (1–6 years of age), middle (7–14 years of age), and older horses (more than 15 years of age). Descriptive statistics were calculated providing mean and standard deviation (SD) or medians with interquartile ranges for continuous variables, frequency, and percentage for categorical variables.
With the main aim of providing valid information essential for sample size calculation of future research, any associations between baseline features and laboratory test results were investigated. Either the Chi-square test or the Fisher exact test was applied to compare qualitative variables. The Kruskal–Wallis nonparametric test was applied to compare differences between quantitative variables.
The agreement between the methods applied to collect DNA from mares (vaginal and uterine swabs) and stallions (urethral swab and seminal fluid) was first evaluated in a contingency table. The degree of accuracy and reliability in positive/negative cases classification was evaluated applying the Cohen’s kappa coefficient [30], and the 95% CIs were calculated by the method proposed by Fleiss et al. [30]. The kappa coefficients were evaluated using the guideline outlined by Landisand Koch [31], where the strength of the kappa coefficients is slight if K = 0.01–0.20, fair if K = 0.21–0.40, moderate if K = 0.41–0.60, substantial if K = 0.61–0.80, and almost perfect if K = 0.81–1.00.
The preliminary results of this study were used to calculate the sample size of horses to be included in a population-based study aimed at estimating the true prevalence of Chlamydia spp. in Sardinia, with a specified level of confidence and precision, assuming a test with imperfect sensitivity and specificity. First, true prevalence was estimated using the prevalence found in this study as assumed. Inputs were the sample size, the number of positives, the desired level of confidence (95%), the desired precision of the estimate (0.05%), and the assumed values for sensitivity (0.7) and specificity (0.9) of the test. Confidence limits for apparent and true prevalences were calculated [32,33]. Subsequently, the population-based study sample size was calculated for an assumed large (infinite) population.
All statistical analyses were performed using R software (Version 4.1.2, R-Foundation for Statistical Computing, Vienna, Austria). Sample size calculation was solved by using the epiR package of R software (
Based on these preliminary results, a hypothetical sample size able to estimate the prevalence of Chlamydia in the whole of Sardinia was calculated.
3. Results
3.1. Origin of the Samples and Detection of Chlamydia Species by Molecular and Serological Tests
After thorough clinical examinations and blood analyses, no abnormalities in the general physical status, hematological and biochemical profiles, or cultural and serological test were observed. The mares did not show any ultrasonographic abnormalities.
All uterine, vaginal, urethral, and environmental swabs were found to be negative in the direct immunofluorescence test.
Out of all the analyzed horses, 13 (13/60; 21.6%) tested positive for chlamydial DNA by using the 16S rRNA fragment gene (Table 2). Specifically, the highest number of positive results were recorded from vaginal swabs (8/39; 20.5%), followed by seminal fluid (2/20; 10%) and uterine swabs (2/27; 7.4%). Moreover, one sample from a urethral swab (1/21; 4.8%) and two from seminal fluids (2/16; 10%) tested positive for Chlamydia spp. after molecular analyses (Table 2). Sanger sequencing of the 16S rRNA amplicons generated clear electropherograms for all sequences that exhibited 100% identity with uncultured Chlamydia sp. (GenBank accessions: MT581449), Chlamydia abortus (GenBank accessions: CP024084), and Chlamydia psittaci (GenBank accessions: CP025423) isolated from various hosts worldwide.
Post-amplification and Sanger sequencing of the ompA fragment gene generated 11 sequences that showed 100% identity with ompA C. psittaci strains isolated from ducks in China (Genbank accession number MK630234). No positive results were highlighted for C. abortus (Table 2).
No statistically significant differences were detected between mares and stallions, between age groups, or between breed groups in the probability of being PCR-positive (p-values > 0.05). However, out of the 10 mares that were found to be positive for C. psittaci in this study, nine showed at least one fertility problem. From the preceding season, six barren mares, one fetal resorption, and two cases of endometritis were recorded.
Concordance between PCR tests for chlamydial DNA was evaluated, and the results are reported in Table 3: (a) for mares and (b) for stallions.
As reported in Table 3a, the results of the PCR tests performed by vaginal and uterine swabs in mares highlight the higher ability of vaginal swabs to identify positive samples (four positive samples, of which three were negative in uterine swabs) and good agreement between the tests in identifying negatives (22 samples identified as negatives), with an observed agreement of 85%. The Cohen’s K coefficient of 0.25 indicates a fair agreement between tests. In stallions (Table 3b), a substantial agreement of 87.5% was found by comparison between urethral swabs and seminal fluids, with moderate agreement between tests (Cohen’s K coefficient = 0.45).
3.2. Detection of Chlamydia Species in the Environment
The 16S rRNA PCR was applied to 24 DNA sequences extracted from environment swabs and water samples. Specifically, three swabs collected from the general pond, the service center, and Garden 1 were found to be positive for Chlamydia spp. (3/8; 37.5%). Chlamydial DNA was also detected in five water samples (5/16; 31.5%) collected from the senior mares’ area, the mares’ pond, the stallions’ area, and Garden 2 (n = 2). The results are summarized in Table 4.
We succeeded in sequencing the 16S rRNA gene sequences from 8 to 24 positive samples that matched uncultured Chlamydia sp. (GenBank accessions: MT581449), Chlamydia abortus (GenBank accessions: CP024084), and Chlamydia psittaci (GenBank accessions: CP025423) isolated from various hosts worldwide in BLASTN searches. However, sequencing was not achieved for four environmental samples that generated an unclear chromatogram and were excluded from the analysis. Due to the high degree of similarity with the strains as above, C. abortus and C. psittaci ompA- and pmp-specific PCR was applied to all positive samples. The ompA genotyping was then applied to eight C. psittaci-positive samples. As a result, the nucleotide sequence identities of the ompA gene between the isolates was 100% identical to Chlamydia psittaci strains (GenBank Accession Number: MK630234) as shown in Table 4.
All of the ectoparasites examined in this study were removed from mares and were morphologically identified as Rhipicephalus spp. (n = 1), Hyalomma marginatum (n = 26), Dermacentor marginatus (n = 1), Rhipicephalus sanguineus (n = 19), and Hippobosca equina (n = 5). There were no detectable ticks on stallions at the time of sample collection.
All the ticks and horse flies turned out negative after PCR tests (Table 5).
3.3. Sardinian Survey Sample Size Calculation
Using a sample size of 60 horses, of which 13 were positive for Chlamydia spp., 95% of the desired confidence level and a desired precision of the estimate of 0.05%, and assuming a test sensitivity of 0.7 and specificity of 0.9, the apparent prevalence of Chlamydia spp. was equal to 21.7% (95% CI = 13.1–33.6), while the true estimate was 25.6% (95% CI = 12.5–44.0).
A one-stage cluster-sampling approach was applied to estimate the prevalence of Chlamydia spp. considering a test with imperfect sensitivity and specificity, considering the Sardinian horse farms as a cluster. Sampling stratifications were not included given that all comparisons between sex, age, and breeds did not produce statistically significant results in the probability of detecting Chlamydia spp.
Figure 2 illustrates the sample size required to estimate the true prevalence with a specified level of confidence (95%) and precision (0.05%), considering an overall number of 11.475 horse farms in Sardinia and hypothesizing an assumed true prevalence of 25.6% (95% CI = 12.5–44.0). Supposing to apply a test with a sensitivity of 0.7 and a specificity of 0.9, about 800 farms should be included and sampled to estimate the true prevalence of Chlamydia spp.
4. Discussion
Recent advances in understanding the etiopathogenesis of Chlamydia psittaci in nature have provided a new perspective on the biology and evolution of this microorganism in the equine species [34]. Although primarily a pathogen of birds, from which infection can spill over into humans and other mammalian hosts, C. psittaci has been also identified as an important cause of reproductive loss in equines [35,36,37]. The disease results in late-term abortions and neonatal illness, and zoonotic pathogens can spread to humans through any contact with C. psittaci-infected horses or tissues [35]. However, there are several key questions concerning pathogen–horse interaction, as well as the management of genital infections and, above all, the presence of this microorganism in the environment. Currently, urogenital screening for Chlamydia spp. infection is generally performed only in cases of clinically apparent issues, thus neglecting the subtle role that various animal species play in this pathology.
The results of this pilot study revealed that prevalence of C. psittaci in vaginal swabs was significantly higher compared to uterine swabs. These results are consistent with previous studies [38,39], in which it was confirmed that vaginal swabs are the more appropriate specimens for diagnosis of genital tract infection with Chlamydia species in horses since this technique allows a greater quantity of mucus and cells to be collected and is less dependent on the operator’s skill [38].
The prevalence of C. psittaci in equine vaginal tracts has been previously reported [15]. Experimental infection performed on pregnant sheep with C. psittaci resulted in uteroplacental infections, but it also caused late-term abortion or birth to weak, low-birth-weight lambs. Moreover, infected ewes excreted chlamydial antigen during estrus, and the shedding persisted for over 1 year in vagina, uterus, and oviduct samples with endometrial cells in the basal stroma as the predominant site of infection [40]. All horses screened in this study did not show any classical signs of chlamydiosis despite several being C. psittaci-positive at genital sites. This was in accordance with recent studies where it was highlighted that asymptomatic infections are the most common, and C. psittaci infections in horses can result in reproductive disease which, if left untreated, may progress to infertility and abortion [35]. However, most of the positive horses here screened have a past medical history of reproductive disorders. Six of them failed to become pregnant and showed embryonic resorption as a clinical manifestation of reproductive disorders in one case. Endometritis was also diagnosed in two mares, and in one case, it was associated with edema. Chlamydia psittaci in infected mares has been described in a retrospective study where the pathogen was detected in association with equine abortion cases in Australia [17]. We cannot evaluate if C. psittaci is an emerging cause of equine infectious abortion or an underdiagnosed infection in Sardinia. Future retrospective studies would confirm this point as well as the involvement of C. psittaci in equine reproductive disorders. The greater positivity observed in the seminal vesicles is probably due to a greater presence of the microorganism in these tissues, which act as reservoirs in urogenital transmission [41].
An abundance of Chlamydia species belonging to the Chlamydiaceae family and including C. psittaci has recently been identified in Sardinian tick species [27], suggesting they may be a vector of infection. However, ticks removed from horses and tested here by a validated chlamydiales-specific PCR gave negative results for Chlamydia species. The presence of C. psittaci in ticks from horses should be further explored considering their vector potential.
The molecular results also confirmed the circulation of C. psittaci strains in environmental samples, specifically in water. Since the circulation of this species has not previously been reported in the Sardinian environment, this result represents the more interesting finding in this study.
The ompA sequences generated in this study shared the same genotypes as those in the SZ15 C. psittaci strain from Asian ducks [42]. The same strain has been recently described in humans with pneumonia in Zhejiang Province [43], and these findings suggested that C. psittaci may infect humans in different regions via bird migration. Moreover, generated ompA sequences also showed 99% similarity to ompA from ST24 (6BC) strains, a well-described avian Chlamydia type strain of considerable public health importance [44,45]. This is the dominant strain typed to date in Australian equine samples, psittacine birds, and humans by multilocus sequence typing (MLST) that emerged as the “gold standard” methodology for molecular characterization of strains [46,47].
Importantly, the C. psittaci strains here obtained from the environment were the same as those detected in the horses here screened. In this context, an indirect transmission from a contaminated environment to C. psittaci-infected horses presumably via fecal contamination of non-migratory avifauna could be hypothesized. In fact, although C. psittaci needs a host during the replicative phase, its elementary bodies can persist in soil and water following shedding from infected birds [48]. However, this remains speculative, since no samples from wild birds have been included in this study. These results emphasize the need to adopt surveillance measures to prevent the spread of C. psittaci infection between horses and to decrease the risk of human infection. This information has been partially reported by other authors; however, they did not report the traceability of the strain in both the environmental samples and the examined subjects [49,50].
In addition, the identical sequences of C. psittaci recently reported in parrots housed in a pet shop in South Sardinia [51] indicate the spread of this strain in the island and the need of planning more control strategies and prevention in the study area. Human disease caused by C. psittaci is often under-reported, and complete information about the patients is not always available.
As previously observed in the literature, the results obtained through direct immunofluorescence have demonstrated that nucleic-acid-based detection methods are more sensitive and can detect low levels of this microorganism [36]. This indicates that there are differences in the sensitivity and specificity of different diagnostic tools used to reveal chlamydial infections in horses. However, some diagnostic tools could not detect the presence of C. psittaci, which leads to the misidentification of this pathogen including the underestimation of the prevalence of chlamydial infections. Therefore, the negative IFD results may reflect the fact that these matrices are not the best target for the detection of Chlamydia species in equids. The positive results obtained with DNA-based methods confirm the test’s sensitivity differences. On the other hand, a positive serological test indicates the exposure to these microorganisms rather than actual evidence of bacterial replication.
Although the C. psittaci ompA genotyping method is limited in its sensitivity in comparison with qPCR assays (which are the current diagnostic standard in the field), we rely on this limitation to provide preliminary characterization of C. psittaci strains circulating in Sardinia. Considering the strong relevance of psittacosis for human health, the diagnosis of C. psittaci by using Cps-specific qPCR assays will be necessary to provide more sensitive detection and greater specificity of the pathogen.
Moreover, the negative pmp test results for the detection of C. abortus emphasize the hypothesis of the involvement of other chlamydial species than C. psittaci and C. abortus in Sardinia.
To the best of the authors’ knowledge, this is the first study in Sardinia in which C. psittaci was detected in the genital tracts of horses and in environmental samples. Evaluating mares and stallions for the presence of C. psittaci (by laboratory examination of semen or other samples from the reproductive tract) prior to each breeding season is a highly recommended practice to avoid an asymptomatic carrier state in the stallion. Considering that the clinical manifestation of C. psittaci in horses is extremely rare, we will continue with this line of research to confirm the implication of this pathogen in the reproductive disorders of equids.
5. Conclusions
These results indicate the first evidence of C. psittaci in mares, stallions, and environmental samples. Due to the recognized zoonotic potential of this microorganism and to the still-unclear aspects of the pathology in horses, it is necessary to deepen the epidemiology of this disease and increase its biosecurity aspects. It would be appropriate to pay more attention to the presence of this microorganism in equine herds through more assiduous monitoring, including C. psittaci differential diagnosis and the routine application of the vaginal test in females and males.
Conceptualization, G.M. (Gaia Muroni), S.A., G.M. (Giovanna Masala) and V.C.; methodology, G.M. (Gaia Muroni), E.S., G.P.B., D.S., R.C., C.F. and A.T.; software, G.M. (Gaia Muroni), E.S. and V.C.; validation, G.M. (Gaia Muroni), E.S. and V.C.; formal analysis, G.M. (Gaia Muroni) and E.S.; investigation, G.M. (Gaia Muroni); resources, G.M. (Giovanna Masala); data curation, G.M. (Gaia Muroni); writing—original draft preparation, G.M. (Gaia Muroni), S.A., G.M. (Giovanna Masala) and V.C.; writing—review and editing, G.M. (Gaia Muroni), S.A., G.M. (Giovanna Masala), F.L. and V.C.; statistical analysis, F.L.; visualization, G.M. (Gaia Muroni), V.C. and G.M. (Giovanna Masala); supervision, G.M. (Gaia Muroni), F.L., V.C. and G.M. (Giovanna Masala); project administration, G.M. (Gaia Muroni); funding acquisition, G.M. (Giovanna Masala). All authors have read and agreed to the published version of the manuscript.
Ethical review and approval were waived for this study, as this study did not involve any animal experiments. Samples were collected from horses using standard procedures as suggested by AGRIS, Servizio Ricerca Qualità e Valorizzazione delle Produzioni Equine, Ozieri, Italy, and submitted to the Experimental Zooprofilactic Institute of Sardinia for Chlamydia screening. Special authorization for sampling activities was not necessary; this action is regulated by the Italian Ministry of Health and performed in the case of infectious diseases.
Informed consent was obtained from all subjects involved in the study.
Data are contained within the article.
The authors declare no conflicts of interest.
Footnotes
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Enlarge this image.Figure 1. Map of the farms included in this study. Light blue dots: farms where samples were collected. Red dots: farms found to be positive for Chlamydia spp. after PCR analyses.
Enlarge this image.Figure 2. Samples sizes required for true prevalence = 0.25, precision = 0.05 and a range of values of sensitivity and specificity.
Baseline features of the horses involved in the study, by mares (n = 39) and stallions (n = 21). Data are presented as a number (percentage).
| Features | Mares | Stallion |
|---|---|---|
| Breeds | ||
| Anglo-Arabian | 17 | 12 |
| Standardbred | 14 | 0 |
| Arabian | 3 | 4 |
| Thoroughbred | 3 | 3 |
| Italian Saddle | 2 | 0 |
| Oldenburg | 0 | 1 |
| Luxembourg Warmblood | 0 | 1 |
| Age | ||
| Young (1–6 y) | 1 | 1 |
| Middle (7–14 y) | 19 | 10 |
| Old (>15 y) | 19 | 10 |
Results of PCR for Chlamydia spp., C. abortus, and C. psittaci performed on vaginal, uterine, and urethral swabs and seminal fluid collected from the 39 mares and 21 stallions involved in this study. Data are presented as a number (percentage), calculated by sample type.
| Gender | Sample Type | Method | Chlamydia spp. (16S rRNA Screening) | C. abortus | C. psittaci |
|---|---|---|---|---|---|
| Mares (39) | Vaginal swabs (39) | PCR-positive samples | 8 (20.5%) | 0 | 8 (20.5%) |
| Uterine swabs (27) | PCR-positive samples | 2 (7.4%) | 0 | 2 (7.4%) | |
| Total in mares | 10 (25.6%) | 0 | 10 (25.6%) | ||
| Stallion (21) | Urethral swabs (21) | PCR-positive samples | 1 (4.8%) | 0 | 1 (4.8%) |
| Seminal fluid (16) | PCR-positive samples | 2 (10%) | 0 | 0 | |
| Total in stallions | 3 (14.2%) | 0 | 1 (4.8%) | ||
| Overall results | 13 (21.6%) | 0 | 11 (18.3%) | ||
Agreement table matrix. (a) Contingency table between PCR tests performed on vaginal swabs and uterine swabs in mares; (b) contingency table between PCR tests performed on urethral swabs and seminal fluids in stallions. Agreement values are presented as overall agreement frequency, Cohen’s kappa coefficients, and 95% confidence intervals (95% CI).
| a | Uterine Swabs | |||
|---|---|---|---|---|
| Vaginal Swabs | POS | NEG | Total | Substantial Agreement: 85% |
| POS | 1 | 3 | 4 | Cohen’s k: 0.25 |
| NEG | 1 | 22 | 23 | |
| Total | 2 | 25 | 27 | |
| b | Seminal Fluid | |||
| Urethral Swabs | POS | NEG | Total | Substantial Agreement: 87.5% |
| POS | 1 | 0 | 1 | Cohen’s k: 0.45 |
| NEG | 2 | 13 | 15 | |
| Total | 2 | 14 | 16 | |
Environmental samples collected in the farm involved in this study.
| Environmental Samples (n) | Collection Areas | IFD | 16S rRNA | pmp PCR | ompA PCR | GenBank Accession Number |
|---|---|---|---|---|---|---|
| Swabs (8) | Senior mares’ area | 0/8 | 3/8 | 0/8 | 1/8 | C. psittaci |
| Water (16) | Senior mares’ area | 0/16 | 5/16 | 0/16 | 3/16 | C. psittaci |
Tick and fly identification. F = female; M = male; N = nymph; E = engorged; NE: not engorged.
| Sample (n) | Species (n) | Tick Stage, Sex, and Engorgement State (n) | Host (n) | PCR |
|---|---|---|---|---|
| Ticks (46) | Rhipicephalus spp. (1) | FE (1) | 1 | 0 |
| Hy. marginatum (26) | FE (8); FNE (1); MNE (14); ME (2); | 10 | 0 | |
| D. marginatus (1) | MNE (1) | 1 | 0 | |
| Rh. sanguineus (19) | FE (7); FNE (1); MNE (5); ME (1); NE (3); NNE (2); | 7 | 0 | |
| Flies (5) | H. equina (5) | F (5) | 1 | 0 |
References
1. Stokes, H.S.; Berg, M.L.; Bennett, A.T.D. A Review of Chlamydial Infections in Wild Birds. Pathogens; 2021; 10, 948. [DOI: https://dx.doi.org/10.3390/pathogens10080948]
2. Borel, N.; Polkinghorne, A.; Pospischil, A. A Review on Chlamydial Diseases in Animals: Still a Challenge for Pathologists?. Veter Pathol.; 2018; 55, pp. 374-390. [DOI: https://dx.doi.org/10.1177/0300985817751218]
3. Eisenberg, T.; Fawzy, A.; Kaim, U.; Nesseler, A.; Riße, K.; Völker, I.; Hechinger, S.; Schauerte, N.; Geiger, C.; Knauf-Witzens, T. et al. Chronic wasting associated with Chlamydia pneumoniae in three ex situ breeding facilities for tropical frogs. Antonie Leeuwenhoek; 2020; 113, pp. 2139-2154. [DOI: https://dx.doi.org/10.1007/s10482-020-01483-6]
4. Vorimore, F.; Hölzer, M.; Liebler-Tenorio, E.; Barf, L.-M.; Delannoy, S.; Vittecoq, M.; Wedlarski, R.; Lécu, A.; Scharf, S.; Blanchard, Y. et al. Evidence for the existence of a new genus Chlamydiifrater gen. nov. inside the family Chlamydiaceae with two new species isolated from flamingo (Phoenicopterus roseus): Chlamydiifrater phoenicopteri sp. nov. and Chlamydiifrater volucris sp. nov. Syst. Appl. Microbiol.; 2021; 44, 126200. [DOI: https://dx.doi.org/10.1016/j.syapm.2021.126200]
5. Sachse, K.; Bavoil, P.M.; Kaltenboeck, B.; Stephens, R.S.; Kuo, C.-C.; Rosselló-Móra, R.; Horn, M. Emendation of the family Chlamydiaceae: Proposal of a single genus, Chlamydia, to include all currently recognized species. Syst. Appl. Microbiol.; 2015; 38, pp. 99-103. [DOI: https://dx.doi.org/10.1016/j.syapm.2014.12.004]
6. Ravichandran, K.; Anbazhagan, S.; Karthik, K.; Angappan, M.; Dhayananth, B. A Comprehensive review on avian chlamydiosis: A neglected zoonotic disease. Trop. Anim. Health Prod.; 2021; 53, 414. [DOI: https://dx.doi.org/10.1007/s11250-021-02859-0]
7. Weygaerde, Y.V.; Versteele, C.; Thijs, E.; De Spiegeleer, A.; Boelens, J.; Vanrompay, D.; Van Braeckel, E.; Vermaelen, K. An unusual presentation of a case of human psittacosis. Respir. Med. Case Rep.; 2018; 23, pp. 138-142. [DOI: https://dx.doi.org/10.1016/j.rmcr.2018.01.010]
8. Collina, F.; De Chiara, A.; De Renzo, A.; De Rosa, G.; Botti, G.; Franco, R. Chlamydia psittaci in ocular adnexa MALT lymphoma: A possible role in lymphomagenesis and a different geographical distribution. Infect. Agents Cancer; 2012; 7, 8. [DOI: https://dx.doi.org/10.1186/1750-9378-7-8]
9. Dembek, Z.F.; Mothershead, J.L.; Owens, A.N.; Chekol, T.; Wu, A. Psittacosis: An Underappreciated and Often Undiagnosed Disease. Pathogens; 2023; 12, 1165. [DOI: https://dx.doi.org/10.3390/pathogens12091165]
10. Shi, Y.; Chen, J.; Shi, X.; Hu, J.; Li, H.; Li, X.; Wang, Y.; Wu, B. A case of chlamydia psittaci caused severe pneumonia and meningitis diagnosed by metagenome next-generation sequencing and clinical analysis: A case report and literature review. BMC Infect. Dis.; 2021; 21, 621. [DOI: https://dx.doi.org/10.1186/s12879-021-06205-5]
11. Balsamo, G.; Maxted, A.M.; Midla, J.W.; Murphy, J.M.; Wohrle, R.; Edling, T.M.; Fish, P.H.; Flammer, K.; Hyde, D.; Kutty, P.K. et al. Compendium of Measures to Control. Chlamydia psittaci. Infection Among Humans (Psittacosis) and Pet Birds (Avian Chlamydiosis), 2017. J. Avian Med. Surg.; 2017; 31, pp. 262-282. [DOI: https://dx.doi.org/10.1647/217-265]
12. Zhang, Z.; Zhou, H.; Cao, H.; Ji, J.; Zhang, R.; Li, W.; Guo, H.; Chen, L.; Ma, C.; Cui, M. et al. Human-to-human transmission of Chlamydia psittaci in China, 2020: An epidemiological and aetiological investigation. Lancet Microbe; 2022; 3, pp. e512-e520. [DOI: https://dx.doi.org/10.1016/S2666-5247(22)00064-7]
13. Jenkins, C.; Jelocnik, M.; Melinda, L.; O’Rourke, B.; Chicken, C.; Carrick, J.; Polkinghorne, A. An epizootic of Chlamydia psittaci equine reproductive loss associated with suspected spillover from native Australian parrots. Emerg. Microbes Infect.; 2018; 7, 88. [DOI: https://dx.doi.org/10.1038/s41426-018-0089-y]
14. Jelocnik, M.; Branley, J.; Heller, J.; Alderson, S.; Galea, F.; Polkinghorne, A. Multilocus sequence typing identifies an avian-like Chlamydia psittaci strain involved in equine placentitis and associated with subsequent human psittacosis. Emerg. Microbes Infect.; 2017; 6, e7. [DOI: https://dx.doi.org/10.1038/emi.2016.135]
15. Anstey, S.; Lizárraga, D.; Nyari, S.; Chalmers, G.; Carrick, J.; Chicken, C.; Jenkins, C.; Perkins, N.; Timms, P.; Jelocnik, M. Epidemiology of Chlamydia psittaci infections in pregnant Thoroughbred mares and foals. Veter J.; 2021; 273, 105683. [DOI: https://dx.doi.org/10.1016/j.tvjl.2021.105683]
16. El-Hage, C.; Gilkerson, J. Chlamydia psittaci: An emerging cause of equine abortion and fatal neonatal illness in south-eastern Australia. VetRec.; 2023; 193, 11. [DOI: https://dx.doi.org/10.1002/vetr.3739]
17. Akter, R.; Sansom, F.M.; El-Hage, C.M.; Gilkerson, J.R.; Legione, A.R.; Devlin, J.M. A 25-year retrospective study of Chlamydia psittaci in association with equine reproductive loss in Australia. J. Med. Microbiol.; 2021; 70, 001284. [DOI: https://dx.doi.org/10.1099/jmm.0.001284]
18. Cheong, H.C.; Lee, C.Y.Q.; Cheok, Y.Y.; Tan, G.M.Y.; Looi, C.Y.; Wong, W.F. Chlamydiaceae: Diseases in Primary Hosts and Zoonosis. Microorganisms; 2019; 7, 146. [DOI: https://dx.doi.org/10.3390/microorganisms7050146]
19. Polkinghorne, A.; Greub, G. A new equine and zoonotic threat emerges from an old avian pathogen, Chlamydia psittaci. Clin. Microbiol. Infect.; 2017; 23, pp. 693-694. [DOI: https://dx.doi.org/10.1016/j.cmi.2017.05.025]
20. Szeredi, L.; Hotzel, H.; Sachse, K. High prevalence of chlamydial (Chlamydophila psittaci) infection in fetal membranes of aborted equine fetuses. Veter Res. Commun.; 2005; 29, pp. 37-49. [DOI: https://dx.doi.org/10.1007/s11259-005-0835-1]
21. Costa, L.R.R. History and Physical Examination of the Horse. Manual of Clinical Procedures in the Horse; John Wiley & Sons, Ltd.: Hoboken, NJ, USA, 2017; pp. 27-58. [DOI: https://dx.doi.org/10.1002/9781118939956.ch3]
22. Barrelet, A.; Ricketts, S. Haematology and blood biochemistry in the horse: A guide to interpretation. In Practice; 2002; 24, pp. 318-327. [DOI: https://dx.doi.org/10.1136/inpract.24.6.318]
23. Dascanio, J.; McCue, P. Equine Reproductive Procedures. Washing the Penis Book; John Dascanio, V.M.D.; Patrick McCue, D.V.M. John Wiley and Sons Ltd.: Hoboken, NJ, USA, 2021; 22.
24. Love, C.C. Semen Collection Techniques. Veter Clin. North Am. Equine Pr.; 1992; 8, pp. 111-128. [DOI: https://dx.doi.org/10.1016/S0749-0739(17)30470-4]
25. Estrada-Peña, A.; Mihalca, A.; Petney, T. Ticks of Europe and North Africa; Springer Science and Business Media LLC: Dordrecht, The Netherlands, 2017; [DOI: https://dx.doi.org/10.1007/978-3-319-63760-0]
26. Chisu, V.; Porcu, R.; Tanda, A.; Masala, G. First isolation and characterization of Chlamydophila abortus from abortion tissues of sheep in Sardinia, Italy. Vet. Ital.; 2013; 49, pp. 331-334. [DOI: https://dx.doi.org/10.12834/VetIt.1303.10]
27. Chisu, V.; Foxi, C.; Tanda, A.; Masala, G. Molecular evidence of Chlamydiales in ticks from wild and domestic hosts in Sardinia, Italy. Parasitol. Res.; 2018; 117, pp. 981-987. [DOI: https://dx.doi.org/10.1007/s00436-018-5772-3] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29417274]
28. Doosti, A.; Arshi, A. Determination of the Prevalence of Chlamydia psittaci by PCR in Iranian Pigeons. Int. J. Biol.; 2011; 3, pp. 79-82. [DOI: https://dx.doi.org/10.5539/ijb.v3n4p79]
29. Larkin, M.A.; Blackshields, G.; Brown, N.P.; Chenna, R.; McGettigan, P.A.; McWilliam, H.; Valentin, F.; Wallace, I.M.; Wilm, A.; Lopez, R. et al. Clustal W and Clustal X version 2.0. Bioinformatics; 2007; 23, pp. 2947-2948. [DOI: https://dx.doi.org/10.1093/bioinformatics/btm404]
30. Fleiss, J.L.; Cohen, J.; Everitt, B.S. Large sample standard errors of kappa and weighted kappa. Psychol Bull.; 1969; 72, pp. 323-327. [DOI: https://dx.doi.org/10.1037/h0028106]
31. Landis, J.R.; Koch, G.G. The measurement of observer agreement for categoricaldata. Biometrics; 1977; 33, pp. 159-174. [DOI: https://dx.doi.org/10.2307/2529310]
32. Brown, L.D.; Cat, T.T.; DasGupta, A. Interval Estimation for a proportion. Statistical Science; 2001; 16, pp. 101-133. [DOI: https://dx.doi.org/10.1214/ss/1009213286]
33. Reiczigel, F.; Ózsvári,. Exact confidence limits for prevalence of a disease with an imperfect diagnostic test. Epidemiol. Infect.; 2010; 138, pp. 1674-1678. [DOI: https://dx.doi.org/10.1017/S0950268810000385]
34. Albini, S.; Marti, H.; Imkamp, F.; Borel, N. Update on the zoonotic potential of Chlamydia. Schweiz Arch. Tierheilkd.; 2023; 165, pp. 165-178. [DOI: https://dx.doi.org/10.17236/sat00387]
35. El-Hage, C.; Legione, A.; Devlin, J.; Hughes, K.; Jenkins, C.; Gilkerson, J. Equine Psittacosis and the Emergence of Chlamydia psittaci as an Equine Abortigenic Pathogen in Southeastern Australia: A Retrospective Data Analysis. Animals; 2023; 13, 2443. [DOI: https://dx.doi.org/10.3390/ani13152443]
36. Sachse, K.; Hölzer, M.; Vorimore, F.; Barf, L.-M.; Sachse, C.; Laroucau, K.; Marz, M.; Lamkiewicz, K. Genomic analysis of 61 Chlamydia psittaci strains reveals extensive divergence associated with host preference. BMC Genom.; 2023; 24, 288. [DOI: https://dx.doi.org/10.1186/s12864-023-09370-w]
37. Begg, A.P.; Carrick, J.; Chicken, C.; Blishen, A.; Todhunter, K.; Eamens, K.; Jenkins, C. Fetoplacental pathology of equine abortion, premature birth, and neonatal loss due to Chlamydia psittaci. Veter Pathol.; 2022; 59, pp. 983-996. [DOI: https://dx.doi.org/10.1177/03009858221120008]
38. Schachter, J.; Chernesky, M.A.; Willis, D.E.; Fine, P.M.; Martin, D.H.; Fuller, D.; Jordan, J.A.; Janda, W.; Hook, E.W., 3rd. Vaginal Swabs Are the Specimens of Choice When Screening for Chlamydia trachomatis and Neisseria gonorrhoeae: Results from a Multicenter Evaluation of the APTIMA Assays for Both Infections. Sex. Transm. Dis.; 2005; 32, pp. 725-728. [DOI: https://dx.doi.org/10.1097/01.olq.0000190092.59482.96]
39. Aaron, K.J.; Griner, S.; Footman, A.; Boutwell, A.; Van Der Pol, B. Vaginal Swab vs Urine for Detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis: A Meta-Analysis. Ann. Fam. Med.; 2023; 21, pp. 172-179. [DOI: https://dx.doi.org/10.1370/afm.2942] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/36973065]
40. Papp, J.R.; E Shewen, P.; E Thorn, C.; Andersen, A.A. Immunocytologic detection of Chlamydia psittaci from cervical and vaginal samples of chronically infected ewes. Can. J. Vet. Res. Rev. Can. Rech. Vét.; 1998; 62, pp. 72-74.
41. Cunningham, K.A.; Beagley, K.W. Male Genital Tract Chlamydial Infection: Implications for Pathology and Infertility1. Biol. Reprod.; 2008; 79, pp. 180-189. [DOI: https://dx.doi.org/10.1095/biolreprod.108.067835] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/18480466]
42. Lin, W.; Chen, T.; Liao, L.; Wang, Z.; Xiao, J.; Lu, J.; Xie, Q. A parrot-type Chlamydia psittaci strain is association with egg production drop in laying ducks. Transbound. Emerg. Dis.; 2019; 66, pp. 2002-2010. [DOI: https://dx.doi.org/10.1111/tbed.13248]
43. Yao, W.; Chen, X.; Wu, Z.; Wang, L.; Shi, G.; Yang, Z.; Zhang, Y.; Wu, B. A cluster of Psittacosis cases in Lishui, Zhejiang Province, China, in 2021. Front. Cell. Infect. Microbiol.; 2022; 12, 1044984. [DOI: https://dx.doi.org/10.3389/fcimb.2022.1044984] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/36590592]
44. Taylor, K.A.; Durrheim, D.; Heller, J.; O’Rourke, B.; Hope, K.; Merritt, T.; Freeman, P.; Chicken, C.; Carrick, J.; Branley, J. et al. Equine chlamydiosis—An emerging infectious disease requiring a one health surveillance approach. Zoonoses Public Health; 2018; 65, pp. 218-221. [DOI: https://dx.doi.org/10.1111/zph.12391] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28984040]
45. Stokes, H.S.; Martens, J.M.; Walder, K.; Segal, Y.; Berg, M.L.; Bennett, A.T.D. Species, sex and geographic variation in chlamydial prevalence in abundant wild Australian parrots. Sci. Rep.; 2020; 10, pp. 1-13. [DOI: https://dx.doi.org/10.1038/s41598-020-77500-5] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/33235241]
46. Anstey, S.I.; Kasimov, V.; Jenkins, C.; Legione, A.; Devlin, J.; Amery-Gale, J.; Gilkerson, J.; Hair, S.; Perkins, N.; Peel, A.J. et al. Chlamydia Psittaci ST24: Clonal Strains of One Health Importance Dominate in Australian Horse, Bird and Human Infections. Pathogens; 2021; 10, 1015. [DOI: https://dx.doi.org/10.3390/pathogens10081015]
47. Kasimov, V.; White, R.T.; Foxwell, J.; Jenkins, C.; Gedye, K.; Pannekoek, Y.; Jelocnik, M. Whole-genome sequencing of Chlamydia psittaci from Australasian avian hosts: A genomics approach to a pathogen that still ruffles feathers. Microb. Genom.; 2023; 9, 001072. [DOI: https://dx.doi.org/10.1099/mgen.0.001072]
48. Hulin, V.; Bernard, P.; Vorimore, F.; Aaziz, R.; Cléva, D.; Robineau, J.; Durand, B.; Angelis, L.; Siarkou, V.I.; Laroucau, K. Assessment of Chlamydia psittaci Shedding and Environmental Contamination as Potential Sources of Worker Exposure throughout the Mule Duck Breeding Process. Appl. Environ. Microbiol.; 2015; 82, pp. 1504-1518. [DOI: https://dx.doi.org/10.1128/AEM.03179-15]
49. Kahane, S.; Greenberg, D.; Newman, N.; Dvoskin, B.; Friedman, M.G. Domestic water supplies as a possible source of infection with Simkania. J. Infect.; 2007; 54, pp. 75-81. [DOI: https://dx.doi.org/10.1016/j.jinf.2006.01.011] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/16542731]
50. Wheelhouse, N.; Sait, M.; Gidlow, J.; Deuchande, R.; Borel, N.; Baily, J.; Caldow, G.; Longbottom, D. Molecular detection of Chlamydia-like organisms in cattle drinking water. Veter Microbiol.; 2011; 152, pp. 196-199. [DOI: https://dx.doi.org/10.1016/j.vetmic.2011.03.040] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21549530]
51. Muroni, G.; Pinna, L.; Serra, E.; Chisu, V.; Mandas, D.; Coccollone, A.; Liciardi, M.; Masala, G. A Chlamydia psittaci Outbreak in Psittacine Birds in Sardinia, Italy. Int. J. Environ. Res. Public Health; 2022; 19, 14204. [DOI: https://dx.doi.org/10.3390/ijerph192114204]
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Details
; Serra, Elisa 1 ; Biggio, Giovanni Paolo 2 ; Sanna, Daniela 2 ; Cherchi, Raffaele 2
; Taras, Andrea 2 ; Appino, Simonetta 3 ; Foxi, Cipriano 1
; Masala, Giovanna 1 ; Loi, Federica 4
; Chisu, Valentina 1
1 Istituto Zooprofilattico Sperimentale della Sardegna, 07100 Sassari, Italy;
2 AGRIS, Servizio Ricerca Qualità e Valorizzazione delle Produzioni Equine, 07014 Ozieri, Italy;
3 Dipartimento di Medicina Veterinaria, Università di Sassari, 07100 Sassari, Italy;
4 Osservatorio Epidemiologico Veterinario Regionale della Sardegna, Istituto Zooprofilattico Sperimentale della Sardegna, 07100 Sassari, Italy